Lv41
540 积分 2021-08-09 加入
Efficacy of lifestyle weight loss interventions on regression to normoglycemia and progression to type 2 diabetes in individuals with prediabetes: a systematic review and pairwise and dose-response meta-analyses
8天前
已完结
Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials
8天前
已完结
Cognitive disorders in diabetic patients
10天前
已完结
Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial
11天前
已完结
SGLT2 inhibitors in acute myocardial infarction: what can we learn from the DAPA-MI trial? More news from American Heart Association Scientific Meeting
14天前
已完结
Sodium Glucose Co-Transporter 2 Inhibition Following Acute Myocardial Infarction
14天前
已完结
The effects of dapagliflozin on hepatic and visceral fat in type 2 diabetes patients with non‐alcoholic fatty liver disease
18天前
已完结
Achievement of Guideline-Recommended Targets in Diabetes Care in China
22天前
已完结
Achievement of Guideline-Recommended Targets in Diabetes Care in China
22天前
已完结
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
1个月前
已完结
皖公网安备34019202002308
